Titan Biotech Limited (BOM:524717)

Market Cap	8.17B
Revenue (ttm)	1.74B
Net Income (ttm)	230.64M
Shares Out	8.26M
EPS (ttm)	27.91
PE Ratio	35.41
Forward PE	n/a
Dividend	2.00 (0.20%)
Ex-Dividend Date	Sep 19, 2025

Volume	5,899
Average Volume	6,770
Open	975.00
Previous Close	966.00
Day's Range	960.00 - 1,023.00
52-Week Range	373.65 - 1,419.00
Beta	0.42
RSI	40.84
Earnings Date	Feb 10, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1992
• Employees: 467
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524717

Financial Performance

In 2024, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.